Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 27 March 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Physical, mental, and social problems high with Hep C antivirals

The latest issue of the European Journal of Gastroenterology & Hepatology shows high adverse effects with antiviral therapy in patients with Hep C, that worsen their private and professional relationships, and impact on adherence.

News image

fiogf49gjkf04

The Hepatitis C virus can be successfully treated in up to 60% of infected patients.

However, treatment is long and is associated with significant side-effects.

Dr Susan Zickmund investigated difficulties with this treatment as it is an important factor in patient adherence.

The investigative team enrolled patients receiving Hepatitis C treatment in a tertiary referral center in a cross-sectional study.

The team collected demographic data, functional and emotional status, and co-morbidities from patients or from the medical records.

All participants underwent a semistructured interview, which was analyzed by blinded coders.

A total of 65 patients with a mean age of 46 years, of which 39% were women, were enrolled.

80% described moderate to severe problems attributed to treatment
European Journal of Gastroenterology & Hepatology

The team found that 80% described moderate to severe problems attributed to treatment.

There was a predominance of physical difficulties, including fatigue in 74% of cases, and flu-like symptoms in 32%.

The investigators observed that 38% of patients experienced depression during treatment.

In 31% of cases, physical or emotional problems forced patients to quit their jobs or reduce employment.

The team noted that a fifth of patients attributed deteriorating relationships with friends and family to adverse treatment effects.

Necessary lifestyle adjustments, such as alcohol abstinence, caused frictions with friends in 22% of the participants.

Dr Zickmund's team concluded, “Our findings show a high prevalence of significant adverse effects in patients undergoing antiviral therapy.”

“Whereas the nature and severity of these adverse reactions is consistent with earlier reports, we identified implications with worsening private and professional relationships.”

“To encourage appropriate levels of adherence, healthcare providers should seek information about these indirect treatment effects as they monitor their patients on therapy.”

Eur J Gastroenterol & Hepatol 2006: 18(4): 381
23 March 2006

Go to top of page Email this page Email this page to a colleague

 27 March 2017 
H. pylori infection and preeclampsia
 27 March 2017 
Low-cost oral rotavirus vaccine
 27 March 2017 
 Clostridium difficile and colectomy risk in IBD
 24 March 2017 
MRI for local staging of colon cancer
 24 March 2017 
In-office communication about ulcerative colitis
 24 March 2017 
Prevalence of undiagnosed celiac disease
 23 March 2017 
Suspected nonceliac gluten sensitivity
 23 March 2017 
H. pylori and GERD in children
 23 March 2017 
Prespectives on the management of fecal incontinence
 22 March 2017 
Role of microbiota in colorectal surgery
 22 March 2017 
Disease activity in eosinophilic esophagitis
 22 March 2017 
Abdominal visceral fat and new erosive esophagitis
 21 March 2017 
Global trends in colorectal cancer mortality
 21 March 2017 
Pain in pancreatic cancer
 21 March 2017 
Hepatitis C virus–related hepatic myelopathy
 20 March 2017 
NASH treatment and MRI
 20 March 2017 
Metastasis in human colorectal cancer
 20 March 2017 
Fistula treatment of Crohn’s disease
 17 March 2017 
Microbiota in colorectal cancer 
 17 March 2017 
Among Persons with IBD
 17 March 2017 
Acute liver failure in Scotland
 16 March 2017 
Transition readiness scores in adolescents with IBD
 16 March 2017 
Hepatocellular carcinoma risk in different etiologies of cirrhosis
 16 March 2017 
IBD disability index
 15 March 2017 
European consensus on fecal microbiota transplantation 
 15 March 2017 
Hepatocellular carcinoma in the USA 
 15 March 2017 
Hospital readmission for ulcerative colitis
 14 March 2017 
Cardiovascular diseases risk in Barrett's
 14 March 2017 
Assessment of competence in colonoscopy
 14 March 2017 
Cholecystectomy to prevent recurrent pancreatitis
 13 March 2017 
Gallstone disease after colectomy for ulcerative colitis
 13 March 2017 
Achalasia in Chicago since high-resolution manometry
 13 March 2017 
Vedolizumab exposure in pregnancy
 10 March 2017 
Thiopurine therapy in IBD
 10 March 2017 
Complications in advanced fibrosis in Hep C eradication
 10 March 2017 
Intragastric balloons for obesity-related co-morbidities
 09 March 2017 
Intestinal tuberculosis vs Crohn's disease
 09 March 2017 
Predictors of relapse in children with IBD
 09 March 2017 
Direct-acting antiviral regimen for Hep C genotype 3 
 08 March 2017 
Sterile fecal filtrate transfer for C. diff
 08 March 2017 
Drug-induced liver injury
 08 March 2017 
Pharmacotherapy for alcohol dependence
 07 March 2017 
Psychotropic drugs in functional dyspepsia
 07 March 2017 
Vagus nerve and appetite regulation
 07 March 2017 
Gastrointestinal involvement in systemic sclerosis
 06 March 2017 
Small bowel abnormalities in IBS 
 06 March 2017 
Treatment response in NASH with MRI
 06 March 2017 
Intestinal bacterial overgrowth and PPIs in children
 03 March 2017 
Alcohol and risk of gallstone disease
 03 March 2017 
Smoking at colon cancer diagnosis influences survival
 03 March 2017 
Improvements in Crohn’s Disease outcomes over time
 02 March 2017 
Surviving sepsis guidelines
 02 March 2017 
Tenofovir and Hep B transmission in pregnancy
 02 March 2017 
Diagnosis of pediatric IBD 
 01 March 2017 
Healthcare utilization amonth IBD Veterans
 01 March 2017 
Complications after ileocecal resection in Crohn’s
 01 March 2017 
Fecal microbiotica transplnantation

 28 February 2017 
Smoking and cancer-specific survival in colon cancer
 28 February 2017 
ALT levels and all-cause mortality
 28 February 2017 
American Gastroenterological Association for acute liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us